top of page
Executive Spotlights

Spero Therapeutics Names Sath Shukla as CEO, Ushering in New Era of Growth and Innovation

Cambridge, MA, June 14, 2023 (Globe Newswire) -- Spero Therapeutics, a leading biopharmaceutical company focused on rare diseases and multi-drug resistant bacterial infections, appoints Sath Shukla as President and Chief Executive Officer (CEO). With extensive strategic and financial leadership experience, Shukla will steer the company's mission of delivering groundbreaking solutions to patients in need.


Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma

Σχόλια


Life Science Headlines
bottom of page